Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 5/20 | 0.67 |
| ▸ | PPARD | Q03181 | 5/20 | 0.67 |
| ▸ | PPARA | Q07869 | 5/20 | 0.67 |
| ▸ | F7 | P08709 | 5/20 | 0.67 |
| ▸ | F3 | P13726 | 5/20 | 0.67 |
| ▸ | MAPT | P10636 | 4/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.67 |
| ▸ | TERT | O14746 | 3/20 | 0.67 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.67 |
| ▸ | BLM | P54132 | 3/20 | 0.67 |
| ▸ | FABP4 | P15090 | 3/20 | 0.67 |
| ▸ | LMNA | P02545 | 3/20 | 0.67 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.67 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.67 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.67 |
| ▸ | RECQL | P46063 | 2/20 | 0.67 |
| ▸ | DUSP3 | P51452 | 2/20 | 0.67 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10629296 | 0.93 | LMNA (0.63) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL28938360 | 0.93 | LMNA (0.63) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL1241102 | 0.93 | LMNA (0.63) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL541950 | 0.93 | LMNA (0.63) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL25293847 | 0.91 | PPARG (0.78) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL285160 | 0.91 | PPARG (0.78) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL2937778 | 0.91 | PPARG (0.78) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL864021 | 0.91 | PPARG (0.78) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL3113499 | 0.91 | PPARG (0.78) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL3898132 | 0.91 | PPARG (0.78) | PPARGPPARDPPARAF7F3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080311184-A1 | METHOD FOR DEVELOPING, TESTING, AND USING ASSOCIATES OF MACROMOLECULES AND COMPLEX AGGREGATES FOR IMPROVED PAYLOAD AND CONTROLLABLE DE/ASSOCIATION RATES | IDEA AG (DE) | 2008-12-18 | — | — | US | claimed |
| US-20070031483-A1 | Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin | CEVC GREGOR | 2007-02-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070031483-A1 | Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin | CUTA, ABCG2, PIGS | PPARG 1449/4885PPARD 1989/4885PPARA 1111/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.